Related Experiment Video
Updated: Jun 24, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Sudden cardiac death of two heart transplant patients with correctly functioning implantable cardioverter
Raquel Marzoa-Rivas1, Luisa Perez-Alvarez, Maria J Paniagua-Martin
1Heart Failure and Transplant Unit, Complejo Hospitalario Universitario A Coruña, La Coruña, Spain. raquelmarzoa@yahoo.es
Insights
Implantable cardioverter defibrillators may not prevent sudden cardiac death in heart transplant recipients with severe coronary allograft vasculopathy and poor ventricular function. Further research is needed for this high-risk patient group.
Area of Science:
- Cardiology
- Transplantation Medicine
- Sudden Cardiac Death
Background:
- Sudden cardiac death (SCD) risk stratification and management in heart transplant recipients (HTR) remains challenging.
- Standard criteria for implantable cardioverter defibrillator (ICD) implantation may not directly apply to HTRs.
- Coronary allograft vasculopathy (CAV) and impaired ventricular systolic function are significant concerns post-transplantation.
Purpose of the Study:
- To evaluate the efficacy of implantable cardioverter defibrillators (ICDs) in preventing sudden death in heart transplant recipients.
- To investigate the specific challenges in applying general ICD implantation criteria to the heart transplant population.
- To analyze the outcomes of HTRs experiencing sudden death despite functioning ICDs.
Main Methods:
- Case review of two heart transplant recipients who experienced sudden death.
- Review of existing literature on ICDs in heart transplant recipients.
- Analysis of patient characteristics, including presence of coronary allograft vasculopathy and ventricular systolic function.
Main Results:
- Two cases of sudden death occurred in heart transplant recipients with properly functioning ICDs.
- The reviewed literature suggests limited benefit of ICDs in specific HTR subgroups.
- The highest incidence of sudden death was observed in HTRs with severe coronary allograft vasculopathy and poor ventricular systolic function.
Conclusions:
- Implantable cardioverter defibrillators are unlikely to be effective in preventing sudden death in heart transplant recipients with severe coronary allograft vasculopathy and reduced ventricular systolic function.
- Current ICD implantation criteria may need modification for heart transplant recipients, particularly those with advanced CAV.
- This high-risk group warrants specialized consideration for SCD prevention strategies.
Abstract:
It is unclear whether the usual criteria for implantation of implantable cardioverter defibrillators in patients at risk of sudden death can be generalized to heart transplant recipients. We describe sudden death in 2 heart transplant recipients despite correctly functioning implantable cardioverter defibrillators. The scant relevant literature is reviewed. We conclude that implantable cardioverter defibrillators are unlikely to assist heart transplant recipients with severe coronary allograft vasculopathy and poor ventricular systolic function, the group with the highest incidence of sudden death.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiopulmonary Resuscitation III: AED Use
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
